Lipella Pharmaceuticals Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 536 | 450 | 184 | 259 | 962 |
| Gross Profit | 536 | 450 | 184 | 259 | 962 |
| Operating Expenses | 5,617 | 5,196 | 2,774 | 2,175 | 1,019 |
| Operating Income | -5,081 | -4,746 | -2,590 | -1,916 | -57 |
| Interest Expense | 0 | 11 | 10 | 7 | 8 |
| Other Income | 64 | 138 | 2 | 57 | 3 |
| Pre-tax Income | -5,016 | -4,619 | -2,598 | -1,866 | -62 |
| Net Income Continuous | -5,016 | -4,619 | -2,598 | -1,866 | -62 |
| Net Income | $-5,016 | $-4,619 | $-2,598 | $-1,866 | $-62 |
| EPS Basic Total Ops | -4.79 | -6.16 | -5.12 | -4.40 | -0.08 |
| EPS Basic Continuous Ops | -4.79 | -6.16 | -5.12 | -4.38 | -0.09 |
| EPS Diluted Total Ops | -4.79 | -6.16 | -5.12 | -4.40 | -0.08 |
| EPS Diluted Continuous Ops | -4.79 | -6.16 | -5.12 | -4.38 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -4.79 | -6.16 | -5.12 | -1.76 | N/A |
| EBITDA(a) | $-5,078 | $-4,744 | $-2,590 | $-1,916 | $-57 |